This manuscript submitted by Noormohammadi and colleagues identifies a novel regulatory pathway keeping stem cells more 'youthful' than other cells. The authors demonstrate that hESCs have a higher abundance of specific CCT subunits (3, 4, 5, 6A, and 8) than differentiated cells. More strikingly, hESCs appear to have a substantially higher levels of assembled CCT as compared to differentiated cells. Decreasing CCT subunit levels promotes hESC differentiation, suggesting that an enhanced protein quality control network is a necessary condition for maintenance of pluripotency.
CCT7. Is that 8-9 different wells within one single experiment? Or are these true independent experimental replicates of 3-5 wells, 8-9 different times? Minimum of three biological replicates would be required in 3 independent PSC lines in 1 experiment. Then the assay and phenotype data should be averaged for the group. Then each assay has to be repeated a minimum of 3 times (for every hESC/hiPSC line) in the same experiment. Then the data should be averaged and compared across the groups. Multiple wells in 1 experiment do not qualify as independent experiments. For the HD iPSCs, a minimum n of 3-4 patients is required per group for comparison, which is now the standard for iPSC disease models being accepted and published in high impact journals. The authors also need to have an equal number of control subject iPSC lines. In figures 3 and 4 where C. elegans data is presented and the n's are described as 77/96 and so on, please clearly describe is this an aggregate (meta-analysis) of the n's over multiple experiments and same/different stocks. If so, how many? Given the significant variability in differentiation of iPSC-derivatives from experiments a minimum of 3 experimental replicates are required and data averaged over those experiments. E. Conclusions: robustness, validity, reliability For the many specific experiments conducted the conclusions are valid. However, there is a lack of clarity regarding the significance and role of each of the subunits in human vs C. elegans data. In Figure 1 , in human cells it is clear the CCT8, CCT7, CCT6A and CCT2 are important for pluripotency in hESCs and assembly of TRiC/CCT complex. Here CCT1 does not seem to be critical in this process. In Figure 2 , in human cells it is clear that knockdown CCT7, CCT6A and CCT2 affects pluripotency and proteostasis. It is not clearly explained why CCT8 drops out of these experiments? In Figure 3 and 4, in C elegans, it cct-8 are the most important subunit in increasing longevity and proteotoxic stress. The human ortholog of the c elegans cct-8, CCT8 does not appear to be as critical in affecting proteotoxic stress. This rationale for this should be explained. As a result of the discrepancies in the results between the different CCT subunits across the multiple species it is very difficult to follow the paper. Importantly, the reliability of the phenotypes cannot be ascertained due to the minimal number of PSCs utilized in each experiment group. Suggested improvements: experiments, data for possible revision 1. Figure legend 2C . Knock down of CCT6A and CCT7 does not appear to induce expression of endoderm markers at all. Rather it should say ectoderm. Please correct this. Also, it is rather curious as to why the knockdown does not affect mesoderm and endoderm expression in 2C. The authors need to explain clearly the rationale behind this? 2. Clarify the statistics as stated previously. 3. Evaluate and include publicly available transcriptome data regarding levels and relevance of the chaperome. There is also GEO data from published HD iPSC studies that have shown some or no phenotypes in the differentiated neurons. 4. Incorporate allelic series of CAG repeat HD iPSC lines. 5. Clarify differences in species and different CCT subunits and their relevance to proteotoxic stress. 6. It would be ideal if the authors can include levels CCT subunit proteins of WT and HD BAC mice primary striatal neurons. 7. Explain why CCT6A and CCT7 knockdown is mostly ineffective in mesodermal and endodermal gene expression. Perhaps include a larger set of germ layer specific genes. 8. Show other relevant controls of inducing proteotoxic stress in human ESC/iPSCs and differentiated neurons with inhibition of proteasomes (bortezomib) or inhibition of Hsp90 (geldanamycin) F. References: appropriate credit to previous work? References have been appropriately cited except for some of the citations mentioned in this review. G. Clarity and context: lucidity of abstract/summary, appropriateness of abstract, introduction and conclusions Overall, the paper is apprehensible and well-written including the abstract. Introduction is sound, although a more clear description of the difference and relevance of the CCT subunits in engendering proteotoxic stress across human cells and C. elegans should be clarified better. The conclusions and their interpretations about many of in vitro results with HD iPSCs are much overstated without additional HD iPSC donor lines.
Reviewer #3 (Remarks to the Author)
The observations that TRiC/CCT complexes are important for hESC pluripotency and can mildly increase lifespan when overexpressed in C. elegans are interesting, and it is always nice to see the combination of mammalian and invertebrate mechanistic experiments in one study. However, there is some convoluted logic that enters the paper with the introduction of C. elegans to the story (see 2-5 below):
1 Reviewer #1 (Expert in protein folding) This manuscript submitted by Noormohammadi and colleagues identifies a novel regulatory pathway keeping stem cells more 'youthful' than other cells. The authors demonstrate that hESCs have a higher abundance of specific CCT subunits (3, 4, 5, 6A, and 8) than differentiated cells. More strikingly, hESCs appear to have a substantially higher levels of assembled CCT as compared to differentiated cells. Decreasing CCT subunit levels promotes hESC differentiation, suggesting that an enhanced protein quality control network is a necessary condition for maintenance of pluripotency.
The authors also demonstrate that the relationship between CCT levels and youthfulness is a generalizable phenomenon, in that it extends C. elegans lifespan as well, in particular under stressful conditions. Finally, in an additional interesting finding, the authors show that there is a clear mechanistic link between enhanced CCT assembly in hESCs and C. elegans and enhanced proteostasis -in that hESCs and organisms become less sensitive to polyQmediated aggregation.
I think this manuscript to be of the highest quality and novelty. It is of high importance to the protein folding field, and it seems to me to be the first interesting finding about CCT in decades. The main thesis of the article, i. e. the link between CCT subunit levels and 'youthfulness' are extremely interesting. What I particularly like is that in addition to its main discoveries, this article also sheds light on a topic that has been somewhat confusing in the field for some time -namely the 'moonlighting' functions of CCT subunits. The data here would suggest that modulating the expression of subunits in isolation may actually modulate the levels of assembled rings, as opposed to simply the level of a given subunit.
Given the highly important, mechanistic, and novel aspects of the manuscript I would strongly recommend publishing it. I have some minor comments, but I view them as optional in light of space limitations. (Fig. 2c) . In contrast, we found a decrease in the levels of CCT1 in its monomeric form upon CCT8 overexpression (Fig. 2c) In this paper the authors have for the first time shown that human pluripotent stem cells have greater levels and assembly of chaperonin complex, TRiC/CCT, than differentiated cell types. These complexes are required at some level for maintaining pluripotency in human PSCs. Perturbing this complex results either in the cell death or decreased pluripotency levels. They also show some evidence of how these enhanced proteostatic capabilities of PSCs may be useful in age-related disease modeling with iPSCs, particularly for a neurodegenerative disease like Huntington's. They then complement their human PSC data using C. elegans model system establishing that proteostatic is also key for self-renewal potential of human ESCs as well as in aging. The advances described in this study are worthy of publication in Nature Communications after some additional data and revisions suggested below. The overall quality and style of presenting the data is and approach taken is valid. Experiments have been carried out with precision. The weakness in this study is related to the HD iPSC modeling portion of the paper in Figure 2 where they are trying to show an application related to the importance of knockdown of CCT subunits in Huntington's disease and accumulation of polyQ aggregates. At least CAG repeats (> 34 CAG repeats) allelic series of from 3 different HD patient donors and their iPSC cell lines are needed as true biological replicates for each group to reach statistically sound conclusions. These HD iPSC lines are now easily available from multiple repositories. The authors could also bolster their conclusions by using multiple clonal HD iPSC lines is from the CAG repeat donor. This is a norm for iPSC disease modeling field now.
Moreover, the CAG repeat length for the HD patient donor iPSC shown in this paper is not described at all. Figure 4 and Supplementary Figures 8-10 .
Reviewer #2 is absolutely right, and several HD-iPSCs carrying different CAG repeat expansions are needed to reach conclusions. In our first submission, we used a control iPSC line and a HD-iPSC line (polyQ71) generated by Prof. Daley's laboratory using retroviral vectors. We have now included a new HD-iPSC line reprogrammed from the same parental fibroblast (polyQ71) using episomal vectors (HD Q71 iPSC line #2 in the manuscript). This line was obtained from NINDS Human Cell and Data Repository (NHCDR). Most importantly, we have now included three new HD-iPSCs from different patient donors (polyQ57, polyQ60 and polyQ180) and two new control iPSC lines from different donors obtained from NHCDR. These data can be found in

We apologize for not describing the CAG repeat length for the HD-iPSC line in our first submission. We have now described the CAG repeat expansion for every HDiPSC line used in this paper (in the corresponding Figures and Methods section).
Most importantly, this paper has NOT evaluated a single phenotype or molecular mechanisms of proteotoxic stress in the relevant neural cell types from the HD iPSCs i.e. the striatal neurons that degenerate in human HD patients. The HD hESCs and hiPSCs studies published thus far have shown no phenotypes. Therefore, it is important to demonstrate relevance of disturbing the proteoatsis and poly Q aggregates in a relevant neuronal cell type. Protocols for striatal neuron differentiation from iPSCs have been now published by multiple labs. PMID: 22748968; PMID: 18922775 This is necessary. Figure 11) .
In our first submission, we did not include any data on relevant neuronal cell types from HD-iPSCs because our main focus was to study proteostasis of pluripotent stem cells. However, Reviewer #2 raises a very important point: Since neurons derived from HD-iPSCs lack HD phenotypes (i.e., neurodegeneration and accumulation of polyQ inclusions), it is interesting to examine the relevance of disturbing proteostasis in
There is also a lack of in-lab HD-iPSC pluripotency validation data described in supplementary figures. Even though iPSCs may be procures from another lab, basic iPSC QC within the lab is required to ensure stable cytogenetics. G-band karyotype (cytogenetic stability) and STR identity analysis is required on all the PSCs used in this study including the H1 and H9 hESCs, as well as the HD-iPSCs. (Fig. 4a) and do not accumulate polyQ aggregates upon knockdown of CCTs (Fig. 4c) . Furthermore, we also confirmed that control iPSC line #1 down-regulates the expression of CCT subunits during differentiation (Supplementary Figure 5a) . As mentioned above, the control iPSCs #1 used in our experiments had a normal, diploid, male, chromosomal content as assessed by SNP analysis.
D. Appropriate use of statistics and treatment of uncertainties
This was one of the major weaknesses in this manuscript. Then n's are mentioned in each figure legend, however, it is not clearly described where the n's are derived from? Are these true biological and experimental replicates or only technical replicates? Is it independent experiments with multiple biological replicates? The statistics should be run on minimum of 3 exclusively performed independent experiments (each experiment containing multiple biological and technical replicates).
We apologize for not clearly describing where the n's are derived from in our first submission. In the corresponding figure legends, Second, it wasn't clear in the figure legends of figure 1 and 2 where and how the statics on the data of the knock down of CCT subunits is derived from. Like, n=8, 9, and 9 for CCT2, CCT6A, CCT7. Is that 8-9 different wells within one single experiment? Or are these true independent experimental replicates of 3-5 wells, 8-9 different times? Minimum of three biological replicates would be required in 3 independent PSC lines in 1 experiment. Then the assay and phenotype data should be averaged for the group. Then each assay has to be repeated a minimum of 3 times (for every hESC/hiPSC line) in the same experiment. Then the data should be averaged and compared across the groups. Multiple wells in 1 experiment do not qualify as independent experiments. Figure 5) . Therefore, we have now observed increased levels of TRiC/CCT complex in three different pluripotent stem cell lines.
We would like to thank
For the HD iPSCs, a minimum n of 3-4 patients is required per group for comparison, which is now the standard for iPSC disease models being accepted and published in high impact journals. The authors also need to have an equal number of control subject iPSC lines.
As mentioned above, we have now used iPSCs from 4 different patient donors (polyQ57, polyQ60, polyQ71 and polyQ180) and three different control iPSCs from different donors.
In figures 3 and 4 where C. elegans data is presented and the n's are described as 77/96 and so on, please clearly describe is this an aggregate (meta-analysis) of the n's over multiple experiments and same/different stocks. If so, how many?
We apologize for not making this point more clear in our first submission. We have presented our lifespan data following the standard style used in aging research manuscripts (e.g., Arantes-Olivera, N. et al (Science, 2002) , Merkwirth, C. (Cell, 2016) , Lapierre, L. et al (Nat. Communications. 2013) 
. Each graph represents a Kaplan-Meier survival plot of a single independent experiment. In each graph, experimental and control animals were grown in parallel and log-rank (Mantel-Cox) statistical test was employed to compare between populations of the experiment. The P-values refer to experimental and control animals in a single experiment. We present a representative experiment in the main text whereas the replicate experiments with their statistical analysis and also independent transgenic lines can be found in the supplementary materials.
In each experiment, we set up the assay with 96 worms for each population being tested. Considering that a portion of the population will be censored, it is advisable to start with approx. 100 worms to achieve meaningful statistics (Amrit, F.R.G. et al, Methods, 2014) Given the significant variability in differentiation of iPSC-derivatives from experiments a minimum of 3 experimental replicates are required and data averaged over those experiments.
. From the initial worm population, the worms that are lost or burrow into the medium as well as those that exhibit 'protruding vulva' or undergo bagging were censored. n= total number of uncensored animals/total number (uncensored + censored) of animals observed in each experiment. We have now made clear this point in the figure legend of the first figure presenting C. elegans data (Figure 5): "Each lifespan graph shows a Kaplan-Meier survival plot of a single representative experiment. In each graph, experimental and control animals were grown in parallel. n= total number of uncensored animals/total number (uncensored + censored) of animals observed in each experiment. P-values refer to experimental and control animals in a single lifespan experiment. See
Supplementary
We averaged and analyzed data of at least 3 experimental replicates in the iPSC figures presented in this manuscript.
E. Conclusions: robustness, validity, reliability
For the many specific experiments conducted the conclusions are valid. However, there is a lack of clarity regarding the significance and role of each of the subunits in human vs C. elegans data.
In Figure 1 , in human cells it is clear the CCT8, CCT7, CCT6A and CCT2 are important for pluripotency in hESCs and assembly of TRiC/CCT complex. Here CCT1 does not seem to be critical in this process.
In Figure 2 , in human cells it is clear that knockdown CCT7, CCT6A and CCT2 affects pluripotency and proteostasis. It is not clearly explained why CCT8 drops out of these experiments? In Figure 3 and 4, in C elegans, it cct-8 are the most important subunit in increasing longevity and proteotoxic stress. The human ortholog of the c elegans cct-8, CCT8 does not appear to be as critical in affecting proteotoxic stress. This rationale for this should be explained.
As a result of the discrepancies in the results between the different CCT subunits across the multiple species it is very difficult to follow the paper. Importantly, the reliability of the phenotypes cannot be ascertained due to the minimal number of PSCs utilized in each experiment group. (Figure 3a and Supplementary Figures 6b-c) . As with CCT2, CCT6A or CCT7, knockdown of CCT8 affects pluripotency to a similar extent. We have also examined the impact of CCT8 knockdown on polyQ aggregation in HD-iPSCs (Figure 4d) (Fig. 2b) (Fig. 2c) and somatic tissues of C. elegans (Fig. 5e) .
Reviewer #2 is right and our previous data could lead to think that there are discrepancies in the results between the different CCT subunits across species. We have now included new experiments and re-written the manuscript to make clear the role of CCT8 as an activator of TRiC/CCT assembly in both human and C. elegans cells.
Given that knockdown of a single subunit is sufficient to induce TRiC/CCT function, we thought that knockdown of three distinct CCT subunits (CCT2, CCT6A and CCT7) was sufficient to demonstrate that increased TRiC/CCT assembly modulates pluripotency and proteostasis in human PSCs. Since we found that CCT8 is sufficient to increase TRiC/CCT assembly and extend lifespan in C. elegans, we agree with Reviewer #2 that it is important to show the effects of knockdown of CCT8 in human PSCs to improve the clarity of the paper. We have now included CCT8 knockdown experiments to examine pluripotency marker levels in hESCs and iPSC lines
Although our data indicates that the downregulation of other CCT subunits could also modulate the decline in TRiC/CCT assembly during differentiation and aging (as we discussed in the main text), our results clearly emphasize the positive role of CCT8 as a key activator of TRiC/CCT assembly. In this regard, we have performed a comparison between the levels of the different CCT subunits in hESCs and their differentiated counterparts
We believe that these experiments strengthened the role of CCT8 as a potent activator of TRiC/CCT assembly and proteostasis. Hence, it is now more clear why this specific subunit is an interesting target to be overexpressed in somatic tissues with the aim to increase proteostasis and examine its effects in the context of aging/proteotoxic resistance of post-mitotic tissues. We have now added the aforementioned results and re-written the manuscript to strengthen the link between CCT8, TRiC/CCT assembly and increased proteostasis across species.
Suggested improvements: experiments, data for possible revision 1. Figure legend 2C . Knock down of CCT6A and CCT7 does not appear to induce expression of endoderm markers at all. Rather it should say ectoderm. Please correct this. Also, it is rather curious as to why the knockdown does not affect mesoderm and endoderm expression in 2C. The authors need to explain clearly the rationale behind this?
We apologize for this mistake. We (Fig. 3c and Supplementary Fig. 7) . Since we observed an up-regulation in specific markers of the three germ layers (Fig. 3c and Supplementary Fig. 7) , our data suggest that hESCs undergo a decline of pluripotency upon knockdown of CCT subunits but they do not differentiate into a particular cell lineage".
2. Clarify the statistics as stated previously.
As discussed above, we have now clarified the statistics in each figure legend.
3. Evaluate and include publicly available transcriptome data regarding levels and relevance of the chaperome. There is also GEO data from published HD iPSC studies that have shown some or no phenotypes in the differentiated neurons. (Cell Reports, 2014) (Supplementary Fig. 1-2 and Supplementary Tables 1-2) . In our transcriptome analysis, we identified 279 chaperome components. Among them, 119 genes were down-regulated and 44 genes were up-regulated during differentiation into NPCs (Supplementary Fig. 1 4. Incorporate allelic series of CAG repeat HD iPSC lines.
A) We have now discussed in more detail the gene expression analysis reported in Brehme et al
As mentioned above, we have now described the CAG repeat expansion for every HD-iPSC line used in this paper (in the corresponding Figures and Methods section).
5. Clarify differences in species and different CCT subunits and their relevance to proteotoxic stress. 25, Jeon et al, Stem Cells, 2012) already showed that MG-132 treatment triggers polyQ aggregation in HD-iPSCs by immunohistochemistry experiments. This publication has been appropriately cited in our manuscript. We also treated HD neurons with proteasome inhibitors (Supplementary Figure 11) . As observed in The HD iPSC Consortium's manuscript (Cell Stem Cell, 2012 (Herbst et al, Neurodegenerative Dis. 2007) . We found that the treatment with an inhibitor of HSP90 chaperones (Bradley et al, Stem Cells 2012) References have been appropriately cited except for some of the citations mentioned in this review.
As explained in section B, we have now discussed this relevant work in our manuscript.
G. Clarity and context: lucidity of abstract/summary, appropriateness of abstract, introduction and conclusions Overall, the paper is apprehensible and well-written including the abstract. Introduction is sound, although a more clear description of the difference and relevance of the CCT subunits in engendering proteotoxic stress across human cells and C. elegans should be clarified better. The conclusions and their interpretations about many of in vitro results with HD iPSCs are much overstated without additional HD iPSC donor lines.
We have addressed these important points. The manuscript is now more clear and the conclusions are supported with additional controls.
Reviewer #3 (Expert in C. elegans aging)
1. Perhaps I missed it, but do TRiC/CCT components decline with passage, increasing senescence, and loss of pluripotency (not just differentiation, as shown)? This would be an important indication of the ability of TRiC/CCT components to maintain "stemness".
We agree with Reviewer #3 that these are very important points to be clarified. We have now re-written the manuscript to make clear that TRiC/CCT components decrease during differentiation and that hESCs maintain their high expression of CCT subunits with passage while they are in an undifferentiated/pluripotent state.
Self-renewal:
We have now examined whether the expression of CCT subunits decrease in hESCs with passage (Figure 1g, h) 6, 7 , the expression of CCT subunits and pluripotency markers did not decline with passage (Fig. 1g, 1h) 2. The observation that germline-less worms, particularly glp-1 mutants, have lower levels of CCT components is odd and undermines the authors' premise, as glp-1 worms are long-lived, yet these data suggest that CCT components are dispensable for this long lifespan. Please explain.
We agree with Reviewer #3 that the levels of CCTs in whole-animal glp-1 worms could suggest that CCT components are dispensable for the long lifespan of these mutant worms. We have now assessed whether CCT components regulate the lifespan of glp-1 mutants (Fig. 7b) . As with daf-2 and eat-2 mutants, we found that loss of function of TRiC/CCT reduces the lifespan of germline-lacking glp-1 worms (Fig. 7b) .
We have now included these data in the manuscript (Fig. 7b) (Supplementary Fig. 12a) . Notably, the levels of CCTs in the intestine of glp-1 germline-lacking mutants are increased compared with the intestine of wild-type worms (Fig. 7c, d ). In addition, we also observed increased expression of cct-8 in somatic tissues of glp-1 mutants as assessed by transcriptional reporter experiments (Fig. 7d) (Hill et all, Science (2000) ). We have now performed immunohistochemistry experiments to assess the expression of CCT components in the germline of adult worms. For this purpose, we used an antibody to CCT1 subunit and found that CCT1 is highly expressed in the germline of wild-type worms compared with the intestine (Supplementary Fig. 12a) (Lundin et al, Developmental Biology (2008) 37, 38 , these experiments confirmed wide expression of cct-8 in somatic cells including neurons or body wall muscle cells (Supplementary Fig. 14) . Somatic expression pattern of cct-8 resembled other cct subunits (e.g., cct-1, cct-2 and cct-7) showing a high expression in pharynx and tail 32, 38 (Supplementary Fig. 14) . The role of CCT in embryogenesis, development and developing gonad has been extensively studied in C. elegans (e.g., Lundin et al. Developmental Biology 2007) . These studies showed that TRiC/CCT complex is required for embryogenesis and larval development. In C. elegans, loss of CCT subunits causes a variety of defects in cell division (Lundin et al. Developmental Biology 2007) . For instance, it affects pronuclear
